Exagen Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
September 23, 2019 13:36 ET
|
Exagen Inc.
SAN DIEGO, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Exagen Inc. Announces Pricing of Initial Public Offering
September 18, 2019 19:14 ET
|
Exagen Inc.
San Diego, CA, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research
August 19, 2019 08:57 ET
|
Exagen Inc.
San Diego, CA and Albuquerque, NM, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers
April 24, 2019 09:55 ET
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, April 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., a leader in helping rheumatologist and their patients in the diagnosis, prognosis, and management of chronic...
JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors
March 26, 2019 08:45 ET
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, March 26, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Exagen Inc. to Present at the Cowen and Company 39th Annual Health Care Conference 2019
February 11, 2019 09:58 ET
|
Exagen Diagnostics, Inc.
Albuquerque, NM and San Diego, CA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Exagen, a leader in autoimmune life sciences, today announced that it will present at the Cowen and Company 39th Annual Health...
Exagen Diagnostics to Present at The Piper Jaffray 30th Annual Heathcare Conference
November 13, 2018 09:30 ET
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, today announced that it will present at the Piper Jaffray 30th Annual...
Exagen, Maker of AVISE Testing, Announces First Blood Test for Anti-CarP, a Breakthrough Bio-marker for Rheumatoid Arthritis
September 11, 2018 10:05 ET
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, the leader in specialty rheumatology testing, announced today availability of the first validated blood test...
Exagen Diagnostics Closes Series F Equity and Debt Raise Totaling $48 Million
September 11, 2017 08:58 ET
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Exagen Diagnostics Inc. (“Exagen”), a commercial stage specialty diagnostic company and exclusive home of AVISE testing,...